FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com OHC is excited to share that the US Food and Drug Administration has approved a new treatment for... Read More
OHC is evaluating a promising new treatment for metastatic HER2-positive breast cancer
OHC
October 29, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com One of every five breast cancers are HER2-positive breast cancers. This type tends to grow and spread... Read More
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com More than six months into the COVID-19 pandemic, fears are growing about the long-term impact on cancer... Read More
OHC doctors are evaluating new treatment for women with advanced ovarian cancer.
OHC
October 20, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com For many women diagnosed with ovarian cancer, their initial treatment, which typically includes... Read More
OHC Exclusively Offers New Immunotherapy Treatment for Advanced Cervical Cancer
OHC
October 19, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com In the past 40 years, the number of cases of cervical cancer and the number of deaths from cervical cancer... Read More
OHC is Helping Change the Lives of Patients with Breast Cancer through Clinical Trials
OHC
October 12, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com Breast cancer is no longer the most common cancer for women in the United States. This is due to decades... Read More
OHC doctors are evaluating two new treatments for classic Hodgkin’s lymphoma that may offer fewer, milder side effects.
OHC
October 9, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing & Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com Classical Hodgkin lymphoma (CHL) is considered a highly treatable blood cancer. Advancements in... Read More
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513-751-2273 EXT. 10143 joan.manzo@usoncology.com In 2003, Cancer Family Care established the Unsung Hero Awards in memory of Joslin Haggart Yeiser. According to... Read More
OHC Earns Coveted Accreditation for High Quality and Patient Safety from the American College of Radiology
OHC
September 25, 2020
The cancer experts at OHC have been awarded a three-year term of accreditation in radiation oncology from the American College of Radiology (ACR), following an extensive and detailed review of the practice’s procedures, staff, equipment,... Read More
Cancer Experts at OHC are Evaluating a New Treatment for Older Adults with Acute Myeloid Leukemia
OHC
September 22, 2020
FOR IMMEDIATE RELEASE Contact: Joanie Manzo Director, OHC Marketing/Physician Services 513.751.2273 EXT. 10143 joan.manzo@usoncology.com Although acute myeloid leukemia (AML) accounts for only about one percent of all cancers, it can be deadly if not... Read More
